Kidney Res Clin Pract.
2018 Sep;37(3):308-309. 10.23876/j.krcp.2018.37.3.308.
Use of erythropoiesis-stimulating agents in obese hemodialysis patients
- Affiliations
-
- 1Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea. sh-park@knu.ac.kr
- KMID: 2447173
- DOI: http://doi.org/10.23876/j.krcp.2018.37.3.308
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The authors' reply: Use of erythropoiesis-stimulating agents in obese hemodialysis patients
- Hemoglobin Variability Associated with Erythropoiesis Stimulating Agents
- Obesity may be erythropoietin dose-saving in hemodialysis patients
- Frequency and Pattern of Hemoglobin Cycling in Korean Hemodialysis Patients Treated with Erythropoiesis Stimulating Agent
- Hemoglobin Variability Associated with Different Erythropoiesis Stimulating Agents in Hemodialysis Patients
